Request a CoronaWatch Meeting

COVID-19 MEETING REQUEST FOCUS

Currently, our attention is limited to COVID-19 response; as such, we are only reviewing meeting requests related to COVID-19.

CoronaWatch Dashboard

seeking submissions

The U.S. government is providing a portal for the 2019 novel coronavirus (COVID-19) medical countermeasures task force as a single point of entry for the submission of market research packages and meeting requests from interested stakeholders.

The U.S. government, in response to the COVID-19 outbreak, seeks information from stakeholders on available medical countermeasures in development. We are particularly interested in products and technologies that have progressed into or beyond clinical trials, have established large-scale cGMP manufacturing capability, or utilize an approved platform. Information regarding diagnostics, therapeutics, vaccines, and other products or technologies relevant to addressing this outbreak are sought.

We ask for a brief description of your product or technology, accompanied by a slide deck, manuscript, publications, or other non-confidential information of your choosing. Please note that while we will use any information you present as market research, submission is no guarantee of a meeting or funding and your submission will be shared across U.S. Government agencies involved in COVID-19 medical countermeasure research and development. Only U.S. government officials are invited to join a CoronaWatch meeting, and are bound by law to maintain confidentiality of what is presented and discussed.

  • Relevant to the U.S. government COVID-19 medical countermeasure research and development efforts and/or Emerging Infectious Disease rapid response capabilities 
  • Utilize an already-approved platform, have non-clinical data suggesting efficacy, and/or have significant manufacturing capability
  • Fully owned or licensed by your organization (you have full IP rights and/or freedom to operate)

CoronaWatch Meeting Process

Submit

Submit basic product information or View/update existing submissions.

Evaluate

We will evaluate your request and route it to the most appropriate resource within the federal government.

Notification

We will schedule a meeting.

OR

A meeting is not scheduled, but your technology is retained for future reference.

Before You Submit:

  • These requests are for market research purposes only and are not considered submissions for potential funding.
  • We are only reviewing meeting requests related to COVID-19.
  • Do not submit multiple requests for the same product or technology.

Submit

Submit basic product information or View/update existing submissions.

Evaluate

We will evaluate your request and route it to the most appropriate resource within the federal government.

Notification

We will schedule a meeting.

OR

A meeting is not scheduled, but your technology is retained for future reference.

Before You Submit:

  • These requests are for market research purposes only and are not considered submissions for potential funding.
  • We are only reviewing meeting requests related to COVID-19.
  • Do not submit multiple requests for the same product or technology.

New to TechWatch?

To enable a rapid-response to the COVID-19 outbreak, BARDA has repurposed our existing TechWatch program to focus on COVID-19 medical countermeasures. These CoronaWatch submissions and meetings aim to give innovators and innovative companies a government-wide platform to discuss their ideas with U.S. government experts, and seek partnership opportunities with a wide range of potential federal partners.

  • Gain visibility for your solution
  • Receive feedback from USG experts
  • Hear techniques and strategies for addressing technical and regulatory challenges
  • Get insight on how your solution could fit within the Government
  • Better prepare you for a formal proposal submission

Note: TechWatch submissions are not considered for potential funding

  • All submissions are voluntary and are for information only. However, submitting complete information may facilitate request routing.
  • Review submitted request by Logging in and selecting View on the My Requests page.
  • If you have additional questions about the TechWatch program, please contact us: TechWatchInbox@hhs.gov.

Note: Entities with a White Paper or proposal currently under review for any ASPR solicitation are not eligible to schele a TechWatch meeting related to that submission. If you have concerns regaring your eligibility, please raise them with our TechWatch team as soon as possible.

  • Public Law passed by Congress and signed by the President, December 2006 (PAHPA, PAHPRA, PAHPAIA, 21st Century Cures)
  • Active outreach and scouting to improve the Nation’s public health and medical preparedness and response capabilities
  • Web based infrastructure to facilitate outreach and meetings with stakeholders
  • Key engagement function during routine and emergency operations